Pharma: Other news to note
Thursday, December 12, 2013
Iroko Pharmaceuticals LLC, of Philadelphia, said its affiliate, Iroko Pharmaceuticals Inc., has signed licensing agreements with Algorithm SAL and PT Pratapa Nirmala (Fahrenheit), under which the two companies will obtain the exclusive rights to market and sell pain drug Zorvolex (diclofenac) capsules to countries in the Middle East, North Africa and Indonesia, respectively.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.